Enveric Biosciences Inc share price logo

Enveric Biosciences Inc Share Price

NASDAQ: ENVB

Small Cap

$0.90

+0.18

(+24.36%)

as on

Enveric Biosciences Inc Stock Performance

as on October 16, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $0.79
    $0.91
    downward going graph

    12.22%

    Downside

    1.11%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.56
    $8.33
    downward going graph

    37.71%

    Downside

    825.00%

    Upside

    downward going graph

Enveric Biosciences Inc share price movements today

Previous Close
$0.72
Open
$0.80
Volume
3.9M
Day's Low - High
$0.79 - $0.91
52 Week Low - High
$0.56 - $8.33

Enveric Biosciences Inc Historical Returns

1 Month Return
-1.63 %
3 Month Return
-28.56 %
1 Year Return
-87.56 %
3 Year Return
-98.25 %
5 Year Return
0 %

Enveric Biosciences Inc Stock Fundamentals & Key Indicators

Check Enveric Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.5M

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-9.7M

Revenue (TTM)

35.4M

Profit Margin

0.00%

Return On Equity TTM

0.00%

Enveric Biosciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Enveric Biosciences Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Enveric Biosciences Inc image
Enveric Biosciences Inc
BUY$4.5MNANA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$61.5B223.43%-505.15-12.96%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$37.1BNANA-3.89%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$105.7B87.04%28.9931.86%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$59.6B-3.89%14.0731.37%

Stock Returns calculator for Enveric Biosciences Inc Stock including INR - Dollar returns

The Enveric Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Enveric Biosciences Inc investment value today

Current value as on today

₹17,078

Returns

₹82,922

(-82.92%)

Returns from Enveric Biosciences Inc Stock

₹87,569 (-87.57%)

Dollar Returns*

₹4,647 (+4.65%)

Analyst Recommendation on Enveric Biosciences Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Enveric Biosciences Inc. Average target price of $10

Enveric Biosciences Inc Share Price Target

Get share price movements and forecasts by analysts on Enveric Biosciences Inc.

What analysts predicted

91%UPSIDE

Target Price

$10

Current Price

$0.9

Analyzed by

8 Analysts

Target

$10.00

Enveric Biosciences Inc target price $10, a slight upside of 91% compared to current price of $0.9. According to 8 analysts rating.

Enveric Biosciences Inc Stock’s Investor Sentiment and Interest

Investment in Enveric Biosciences Inc Shares on INDmoney has grown by 1383.33% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:1383.33% versus previous 30 day period

Search interest for Enveric Biosciences Inc Stock has increased by 247% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:247% versus previous 30 day period

Enveric Biosciences Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
0
-
-
-
0
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-4
-5
-3
-2
-2
-1
-2
-3
-2
-2
EBITDA
-4
-5
-3
-4
-2
-1
-1
-3
-2
-2
Interest Expense
0
0
0
0
0
0
0
-
-
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-4
-6
-2
-3
-2
-1
-2
-3
-2
-2
Income Tax Expense
0
0
0
0
0
0
-
0
-
-
Net Income
-4
-6
-2
-3
-2
-1
-2
-3
-2
-2
Net Profit Margin
0.00%
0.00%
0.00%
-530.98%
0.00%
0.00%
0.00%
-926.81%
0.00%
0.00%

Enveric Biosciences Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
15
36
48
42
39
39
-
-
-
-
Gross Profit
5
6
10
8
8
0
0
0
0
0
Operating Income
-1
-5
-11
-7
-6
-5
-64
-19
-16
-9
EBITDA
0
-4
-7
-6
-2
-6
-63
-19
-16
-9
Interest Expense
0
0
0
0
0
0
0
0
0
-
Depreciation
-
-
3
2
2
0
0
0
0
0
Income Before Tax
-2
-6
-11
-10
-5
-6
-56
-19
-17
-9
Income Tax Expense
0
-3
-2
6
0
0
-7
-1
0
0
Net Income
-1
-2
-9
-16
-5
-6
-48
-18
0
-9
Net Profit Margin
-11.83%
-7.69%
-18.67%
-39.30%
-14.04%
-16.00%
0.00%
0.00%
0.00%
0.00%

Enveric Biosciences Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-6
-2
-3
-2
-1
-2
-3
-2
-2
Operating Cash Flow
-4
-2
-1
-2
-2
0
-1
-2
-1
Investing Cash Flow
0
0
0
-
-
-
-
-
-
Financing Cash Flow
-1
0
0
6
0
0
0
4
0
Change in Cash
-5
-2
-1
4
-2
0
0
2
-1

Enveric Biosciences Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-2
-11
-16
-6
-6
-48
-18
-17
-9
Operating Cash Flow
-2
-2
-2
-2
-3
-11
-17
-14
-7
Investing Cash Flow
-6
0
-3
0
0
2
0
0
-
Financing Cash Flow
8
7
2
0
0
24
18
-1
7
Change in Cash
0
3
-3
0
1
15
0
-15
0

Global Institutional Holdings in Enveric Biosciences Inc

Funds
Holdings
AdvisorShares Investments, LLC
3.19%
Renaissance Technologies Corp
1.14%
Geode Capital Management, LLC
0.87%
UBS Group AG
0.84%
Virtu Financial LLC
0.64%
See all

Enveric Biosciences Inc News & Key Events

  • img

    Today's Timeline - 15 October

    Wed, 06:00 PM

    -

    Enveric Biosciences hires Fish and Richardson to contest Gilgamesh Pharmaceuticals' PGR petition against its U.S. Patent No. 12,138,276.

Insights on Enveric Biosciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, ENVB stock has moved up by 27.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 56.5% return, outperforming this stock by 144.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 153.5% return, outperforming this stock by 251.7%

About Enveric Biosciences Inc

ameri100 embodies a value system of ambition, mastery, excitement, reliability and integrity. with these values, the company is becoming an emerging global leader in sap technologies. ameri100, founded in 2013 has rapidly grown through strategic acquisitions. headquartered in princeton, new jersey, with offices in new york, georgia, kansas, pennsylvania, arizona, toronto- canada and bangalore, mumbai, chennai in india, ameri100 brings 500+ of its own best-in-class resources. the company has also evolved a unique partner ecosystem, which adds more than 4500+ resources to its delivery muscle power. ameri100 deals with sap enterprise services, digital transformation, cloud solutions, business intelligence & analytics, mobile applications and professional services. the company is also making strategic investments in artificial intelligence (ai), internet of things (iot) and robotic process automation (rpa). insight to impact!
OrganisationEnveric Biosciences Inc
Headquarters245 First Street, Cambridge, MA, United States, 02142
CEODr. Joseph Edward Tucker Ph.D.
E-voting on sharesClick here to vote

Key Management of Enveric Biosciences Inc

Name

Title

Dr. Joseph Edward Tucker Ph.D.

CEO & Director

Mr. Kevin M. Coveney CPA

Chief Financial Officer

Dr. Peter J. Facchini Ph.D.

Chief Innovation Officer

FAQs

What is Enveric Biosciences Inc share price today?

Enveric Biosciences Inc share price today is $0.9 as on at the close of the market. Enveric Biosciences Inc share today touched a day high of $0.91 and a low of $0.79.

What is the 52 week high and 52 week low for Enveric Biosciences Inc share?

Enveric Biosciences Inc share touched a 52 week high of $8.33 on and a 52 week low of $0.56 on . Enveric Biosciences Inc stock price today i.e. is closed at $0.9,which is 89.19% down from its 52 week high and 60.54% up from its 52 week low.

What is Enveric Biosciences Inc's market capitalisation today?

Enveric Biosciences Inc market capitalisation is $0.00T as on .

How to invest in Enveric Biosciences Inc Stock (ENVB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Enveric Biosciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Enveric Biosciences Inc Shares that will get you 1.6667 shares as per Enveric Biosciences Inc share price of $0.9 per share as on October 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Enveric Biosciences Inc Stock (ENVB) from India?

Indian investors can start investing in Enveric Biosciences Inc (ENVB) shares with as little as ₹87.83 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.30 in Enveric Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Enveric Biosciences Inc share’s latest price of $0.9 as on October 16, 2025 at 1:29 am IST, you will get 11.1111 shares of Enveric Biosciences Inc. Learn more about fractional shares .